Manufacture of homogenised food preparations and dietetic food
BIOPHARMA AS
Revenue 2024
NOK 28.3m
Operating profit
NOK 5.6m
Equity
NOK 5.9m
Incorporated
2000
Employees
8
Share capital
NOK 30,000
Key figures · 2024
Current ratio
1.60
Equity ratio
32.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 19.9% | |
| Net margin (%%) | 16.9% | |
| Return on assets (%%) | 31.2% | |
| Likviditet | ||
| Current ratio | 1.60 | |
| Working capital | 6.7m | |
| Soliditet | ||
| Equity ratio (%%) | 32.5% | |
| Debt-to-equity ratio | 2.08 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.